ARIAD Pharmaceuticals completes rolling submission of ponatinib NDA with FDA ARIAD Pharmaceuticals.

The Committee for Medicinal Products for Human Make use of has granted ARIAD’s request for accelerated assessment of the MAA.. ARIAD Pharmaceuticals completes rolling submission of ponatinib NDA with FDA ARIAD Pharmaceuticals, Inc. today announced it has finished the rolling submission of the New Drug Program for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration . ARIAD supplied the FDA with remaining chemistry, developing, and settings data.Major pharmacy chains – – such as CVS, Rite-Aid and Walgreen – – are holding Plan B in every their stores and have pledged to make sure that customers can purchase it at each shop even if a particular employee declines to market the pill because of moral objections . Kroger has a similar plan for prescription medications however, not for over-the-counter drugs, such as Plan B, Glynn Jenkins, a spokesperson for Kroger, said. Jenkins said that every store decides whether to transport nonprescription Plan B, simply as they do for other nonprescription items.